Identification of Clonal Hematopoiesis Driver Mutations through In Silico Saturation Mutagenesis.

IF 29.7 1区 医学 Q1 ONCOLOGY Cancer discovery Pub Date : 2024-09-04 DOI:10.1158/2159-8290.CD-23-1416
Santiago Demajo, Joan E Ramis-Zaldivar, Ferran Muiños, Miguel L Grau, Maria Andrianova, Núria López-Bigas, Abel González-Pérez
{"title":"Identification of Clonal Hematopoiesis Driver Mutations through In Silico Saturation Mutagenesis.","authors":"Santiago Demajo, Joan E Ramis-Zaldivar, Ferran Muiños, Miguel L Grau, Maria Andrianova, Núria López-Bigas, Abel González-Pérez","doi":"10.1158/2159-8290.CD-23-1416","DOIUrl":null,"url":null,"abstract":"<p><p>Clonal hematopoiesis (CH) is a phenomenon of clonal expansion of hematopoietic stem cells driven by somatic mutations affecting certain genes. Recently, CH has been linked to the development of hematologic malignancies, cardiovascular diseases, and other conditions. Although the most frequently mutated CH driver genes have been identified, a systematic landscape of the mutations capable of initiating this phenomenon is still lacking. In this study, we trained machine learning models for 12 of the most recurrent CH genes to identify their driver mutations. These models outperform expert-curated rules based on prior knowledge of the function of these genes. Moreover, their application to identify CH driver mutations across almost half a million donors of the UK Biobank reproduces known associations between CH driver mutations and age, and the prevalence of several diseases and conditions. We thus propose that these models support the accurate identification of CH across healthy individuals. Significance: We developed and validated gene-specific machine learning models to identify CH driver mutations, showing their advantage with respect to expert-curated rules. These models can support the identification and clinical interpretation of CH mutations in newly sequenced individuals. See related commentary by Arends and Jaiswal, p. 1581.</p>","PeriodicalId":9430,"journal":{"name":"Cancer discovery","volume":" ","pages":"1717-1731"},"PeriodicalIF":29.7000,"publicationDate":"2024-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11372364/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer discovery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1158/2159-8290.CD-23-1416","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Clonal hematopoiesis (CH) is a phenomenon of clonal expansion of hematopoietic stem cells driven by somatic mutations affecting certain genes. Recently, CH has been linked to the development of hematologic malignancies, cardiovascular diseases, and other conditions. Although the most frequently mutated CH driver genes have been identified, a systematic landscape of the mutations capable of initiating this phenomenon is still lacking. In this study, we trained machine learning models for 12 of the most recurrent CH genes to identify their driver mutations. These models outperform expert-curated rules based on prior knowledge of the function of these genes. Moreover, their application to identify CH driver mutations across almost half a million donors of the UK Biobank reproduces known associations between CH driver mutations and age, and the prevalence of several diseases and conditions. We thus propose that these models support the accurate identification of CH across healthy individuals. Significance: We developed and validated gene-specific machine learning models to identify CH driver mutations, showing their advantage with respect to expert-curated rules. These models can support the identification and clinical interpretation of CH mutations in newly sequenced individuals. See related commentary by Arends and Jaiswal, p. 1581.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
通过硅饱和突变鉴定克隆性造血驱动突变
克隆造血(CH)是造血干细胞在影响某些基因的体细胞突变驱动下的克隆扩增现象。最近,克隆性造血与血液系统恶性肿瘤、心血管疾病和其他疾病的发生有关。尽管最常发生突变的CH驱动基因已被确定,但仍缺乏能够引发这一现象的突变的系统性图谱。在这里,我们对 12 个最常发生的 CH 基因进行了机器学习模型训练,以确定它们的驱动突变。这些模型的表现优于专家基于对这些基因功能的先验知识总结出的规则。此外,这些模型在英国生物库近 50 万捐献者中用于识别 CH 驱动基因突变的应用再现了 CH 驱动基因突变与年龄以及多种疾病和病症的患病率之间的已知关联。因此,我们建议这些模型支持在健康个体中准确识别 CH。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Cancer discovery
Cancer discovery ONCOLOGY-
CiteScore
22.90
自引率
1.40%
发文量
838
审稿时长
6-12 weeks
期刊介绍: Cancer Discovery publishes high-impact, peer-reviewed articles detailing significant advances in both research and clinical trials. Serving as a premier cancer information resource, the journal also features Review Articles, Perspectives, Commentaries, News stories, and Research Watch summaries to keep readers abreast of the latest findings in the field. Covering a wide range of topics, from laboratory research to clinical trials and epidemiologic studies, Cancer Discovery spans the entire spectrum of cancer research and medicine.
期刊最新文献
NOTCH1 drives sexually dimorphic immune responses in hepatocellular carcinoma. PKN2 is a dependency of the mesenchymal-like cancer cell state. The UBA1-STUB1 axis mediates cancer immune escape and resistance to checkpoint blockade Survivin promotes stem cell competence for skin cancer initiation Sympathetic Neurons Promote Small Cell Lung Cancer Through the Beta-2 Adrenergic Receptor
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1